BRIDGEWAY CAPITAL MANAGEMENT, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$40,000
-97.4%
33,399
-94.7%
0.00%
-96.4%
Q1 2021$1,512,000
+149.9%
630,002
+207.0%
0.03%
+115.4%
Q4 2020$605,000
+92.7%
205,2000.0%0.01%
+85.7%
Q3 2020$314,000
-38.8%
205,2000.0%0.01%
-30.0%
Q2 2020$513,000
+74.5%
205,200
+42.4%
0.01%
+42.9%
Q1 2020$294,000144,1000.01%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders